Navin Fluorine International Limited has announced a strategic agreement with The Chemours Company to manufacture and ...

Explore Chemours' Q1 2025 earnings insights, highlighting Opteon sales growth, strategic partnerships, and financial outlook amidst market challenges.

With demand for critical minerals picking up and new support from Washington, Chemours (CC) is back in the news. Early in ...

Over 700,000 residents are at risk of serious health problems from cancer-causing pollution. The EPA canceled a small grant to start tackling the problem.

Under the agreement, Navin Fluorine will establish manufacturing facility at Surat, Gujarat, at an estimated capex of $14MN, including $5MN of contribution by Chemours. The project is expected to be ...

Today, an emerging science links the chemical class to a host of diseases: cancer, thyroid issues, endocrine disruption and ...

Navin Fluorine International said that it has entered into a strategic agreement with The Chemours Company to manufacture and establish initial capacity of Opteon two-phase immersion cooling fluid at ...

Chemours (CC) stock fell 10% in extended trading on Tuesday after it missed first-quarter profit estimates and slashed its ...

Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings. Read more to see why CC ...

Today at the Ecosperity Week 2025, Mary L. Schapiro, Chair of the Global Capacity Building Coalition (GCBC), announced the launch of the GCBC Accelerator, a global initiative that will identify, ...

Chevron Phillips Chemical announced today that the shareholders of Chevron Phillips Singapore Chemicals have agreed to sell 100% of their shares to Aster Chemicals and Energy through its affiliate ...

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...